je.st
news
Tag: therapeutics
PsiOxus Therapeutics to Release Study Results of Oncolytic Vaccine Enadenotucirev in Cancer Patients
2014-05-13 11:58:44| Logistics - Topix.net
The EVOLVE trial is a phase I/II trial of intravenous administration of enadenotucirev to patients with epithelial cancers and the MoA trial is a phase I "window of opportunity" trial evaluating intravenous and intra-tumoural administration of enadenotucirev to patients with colon cancer.
Tags: results
study
release
cancer
Antibe Therapeutics Announces Addition to Its Board of Directors and Grant of Options
2014-05-13 02:36:09| Agriculture - Topix.net
Antibe Therapeutics Inc. is pleased to announce the appointment of Samira Sakhia to its Board of Directors.
Tags: of
board
options
addition
Alnylam Presents New Pre-Clinical Data On RNAi Therapeutics Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR)
2014-04-30 06:24:19| drugdiscoveryonline News Articles
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, recently announced the presentation of new pre-clinical data on RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR)
Tags: data
treatment
presents
targeting
Esperion Therapeutics to Present at BioCentury Future Leaders in the Biotech Industry Conference
2014-03-24 18:47:32| Biotech - Topix.net
The presentation and webcast will take place on Friday, March 28, 2014 at 2:30 p.m. Eastern Time.
Tags: present
future
industry
conference
Antibe Therapeutics Announces Non-Brokered Private Placement of $3,000,000
2014-03-22 23:46:12| Semiconductors - Topix.net
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.
Tags: private
placement
announces
therapeutics
Sites : [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] next »